MHR
MRNA icon

Matthew Hamilton Rosenberg’s Moderna MRNA Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-407
Closed -$43K – 847
2024
Q1 		$43K Hold
407
– – 0.01% 445
2023
Q4 		$40.5K Sell
407
-65
-14% -$5.47K 0.01% 457
2023
Q3 		$48.8K Sell
472
-92
-16% -$10.3K 0.02% 425
2023
Q2 		$68.5K Hold
564
– – 0.02% 376
2023
Q1 		$86.6K Buy
564
+35
+7% +$5.77K 0.03% 344
2022
Q4 		$95K Hold
529
– – 0.03% 316
2022
Q3 		$63K Hold
529
– – 0.02% 382
2022
Q2 		$79K Buy
529
+132
+33% +$18.9K 0.03% 350
2022
Q1 		$68K Buy
397
+222
+127% +$37.4K 0.02% 387
2021
Q4 		$44K Buy
+175
New +$51.2K 0.02% 438

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Matthew Hamilton Rosenberg's MRNA Position: Q2 2024 in Review

Matthew Hamilton Rosenberg sold out of Moderna (MRNA) in Q2 2024, closing a stake of 407 shares — an estimated $43K sold.

Matthew Hamilton Rosenberg first reported a position in MRNA in Q4 2021 and held it in 10 quarters. The position peaked at $95K in Q4 2022. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Matthew Hamilton Rosenberg reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 407 Moderna shares in Q2 2024, an estimated $43K.
  • Matthew Hamilton Rosenberg first reported a position in Moderna in Q4 2021 and held it in 10 quarters.
  • Matthew Hamilton Rosenberg's Moderna position peaked at $95K in Q4 2022.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2024, filed 26 Jul 2024.